Showing results (1241-1250 of 2,709) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|January 23, 2025
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation studyKristina L Bajema, Lei Yan, Yuli Li, et al.
The Lancet. Infectious Diseases|October 31, 2024
Review of the WHO guideline on preventive chemotherapy for public health control of strongyloidiasisNathan C Lo, David G Addiss, Dora Buonfrate, et al.
The Lancet. Infectious Diseases|November 1, 2024
Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflowsRebecca E Colman, Marva Seifert, Andres De la Rossa, et al.
The Lancet. Infectious Diseases|December 2, 2024
Barriers and facilitators to the implementation of electronic monitors to improve adherence and health outcomes in patients with tuberculosis: a systematic reviewWenhui Li, Shishi Wu, Min Su, et al.
The Lancet. Infectious Diseases|March 20, 2025
14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy studyVirak Eng, Dysoley Lek, Sitha Sin, et al.
The Lancet. Infectious Diseases|October 19, 2024
Circulation of avian Chlamydia abortus in the Netherlands and community-acquired pneumonia: an outbreak investigation and retrospective cohort studyStijn Raven, Marloes Heijne, Jeroen Koomen, et al.
The Lancet. Infectious Diseases|October 13, 2024
Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulationAhmed Babiker, Sarah Warner, Xiaobai Li, et al.
The Lancet. Infectious Diseases|October 10, 2024
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trialMatthijs P Raadsen, Christine Dahlke, Anahita Fathi, et al.
The Lancet. Infectious Diseases|October 10, 2024
New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidineAndreas K Lindner, Veerle Lejon, Michael P Barrett, et al.
The Lancet. Infectious Diseases|October 10, 2024
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trialYehuda Carmeli, José Miguel Cisneros, Mical Paul, et al.
Pageof 271